AC
COCH icon

Athanor Capital’s Envoy Medical COCH Stock Holding History

Athanor Capital’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-173,816
Closed -$1.7M – 3
2022
Q1 		$1.7M Sell
173,816
-98,670
-36% -$960K 2.32% 16
2021
Q4 		$2.65M Sell
272,486
-6,914
-2% -$67.4K 1.91% 21
2021
Q3 		$2.71M Hold
279,400
– – 0.36% 81
2021
Q2 		$2.71M Buy
+279,400
New +$2.72M 0.1% 143

Other funds holding COCH

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Athanor Capital's COCH Position: Q2 2022 in Review

Athanor Capital sold out of Envoy Medical (COCH) in Q2 2022, closing a stake of 173,816 shares — an estimated $1.7M sold.

Athanor Capital first reported a position in COCH in Q2 2021 and held it in 4 quarters. The position peaked at $2.71M in Q3 2021. 89 funds tracked by Wall St. Rank hold COCH as of Q2 2022.

  • Athanor Capital reported no remaining Envoy Medical position as of Q2 2022 after selling out during the quarter.
  • Athanor Capital sold 173,816 Envoy Medical shares in Q2 2022, an estimated $1.7M.
  • Athanor Capital first reported a position in Envoy Medical in Q2 2021 and held it in 4 quarters.
  • Athanor Capital's Envoy Medical position peaked at $2.71M in Q3 2021.
  • 89 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2022.

Based on Athanor Capital's 13F filing for Q2 2022, filed 11 Aug 2022.